| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T563 |
0-48 |
Sentence |
denotes |
Zhao, 202022Beijing YouAn HospitalBeijingDates: |
| T564 |
49-82 |
Sentence |
denotes |
1/21/2020-2/8/2020Last follow-up: |
| T565 |
83-108 |
Sentence |
denotes |
2/29/2020 n = 77Survival: |
| T566 |
109-172 |
Sentence |
denotes |
6.5% died, 83.1% discharged, 10.4% still hospitalizedInclusion: |
| T567 |
173-233 |
Sentence |
denotes |
Inpatients with COVID-19 based on RT-PCR.Age: m 52 ± 2 ySex: |
| T568 |
234-270 |
Sentence |
denotes |
55.8% femalesGI/liver comorbidities: |
| T569 |
271-312 |
Sentence |
denotes |
10.4% digestive diseasesDisease severity: |
| T570 |
313-349 |
Sentence |
denotes |
74% non-severe, 26% severe Diarrhea: |
| T571 |
350-427 |
Sentence |
denotes |
1.3% (1)Present on admission1/57 nonsevere and 0/20 severeNausea or vomiting: |
| T572 |
428-514 |
Sentence |
denotes |
7.8% (6)Present on admission3/57 nonsevere and 3/20 severeAbdominal pain: NR AST > 40: |
| T573 |
515-582 |
Sentence |
denotes |
26.0% (20)11/57 non-severe and 9/20 severeM 19 (IQR, 21–42)ALT >40: |
| T574 |
583-653 |
Sentence |
denotes |
33.8% (26)17/57 non-severe and 9/20 severeM 28 (IQR, 20–46)BilirubinNR |
